Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.40
+0.30 (3.70%)
At close: Mar 9, 2026, 4:00 PM EDT
8.27
-0.13 (-1.55%)
After-hours: Mar 9, 2026, 7:29 PM EDT
Kyverna Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 480 | 161 | - | - | - |
| Enterprise Value | 314 | -151 | - | - | - |
| Last Close Price | 8.40 | 3.74 | - | - | - |
| PB Ratio | 2.42 | 0.61 | - | - | - |
| P/TBV Ratio | 3.16 | 0.61 | - | - | - |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.19 | 0.23 | 0.09 |
| Net Debt / Equity Ratio | -1.09 | -1.04 | -0.99 | -0.87 | -1.13 |
| Net Debt / EBITDA Ratio | 0.98 | 1.96 | 0.79 | 1.43 | 2.74 |
| Net Debt / FCF Ratio | 1.05 | 2.38 | 0.91 | 1.11 | 3.01 |
| Asset Turnover | - | - | - | 0.09 | - |
| Quick Ratio | 5.05 | 8.47 | 2.90 | 4.29 | 4.78 |
| Current Ratio | 5.16 | 8.61 | 3.06 | 4.46 | 4.84 |
| Return on Equity (ROE) | -70.82% | -80.74% | -125.95% | -52.95% | - |
| Return on Assets (ROA) | -40.75% | -46.93% | -54.89% | -24.10% | - |
| Return on Capital Employed (ROCE) | -111.90% | -52.60% | -112.80% | -53.50% | -37.90% |
| Earnings Yield | -33.55% | -78.95% | - | - | - |
| FCF Yield | -32.88% | -72.13% | - | - | - |
| Buyback Yield / Dilution | -56.07% | -5590.81% | -47.89% | -71.30% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.